EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Genome-based development and clinical evaluation of a customized LAMP panel to rapidly detect, quantify, and determine antibiotic sensitivity of Escherichia coli in native urine samples from urological patients

Moritz Fritzenwanker, Marcel O Grabitz, Vera Negwer, Oliver Schwengers, Borros Arneth, Trinad Chakraborty, Can Imirzalioglu, Florian Wagenlehner

European Journal of Clinical Microbiology & Infectious Diseases · 2025

DOI: 10.1007/s10096-024-05030-3 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2025. Verfasst von Moritz Fritzenwanker und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Microbiology, Justus Liebig University Giessen, Giessen, Germany. Hauptthemen laut MEDLINE: Escherichia coli, Urinary Tract Infections, Escherichia coli Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Justus-Liebig-Universität Gießen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We designed and tested a point of care test panel to detect E.coli and antibiotic susceptibility in urine samples from patients at the point of care in the urological department. The aim of this approach is to facilitate choosing an appropriate antibiotic for urinary tract infections (UTI) at first presentation in the context of increasing antibiotic resistance in uropathogens worldwide.

Methods

We analyzed 162 E.coli isolates from samples from a university urological department to determine phenotypic and genotypic resistance data. With this data we created customized LAMP (loop-mediated isothermal amplification) panels for a commercial machine with which to detect and possibly quantify E.coli and six antibiotic resistance determinants. In a second step we tested these panel(s) for diagnostic accuracy on 1596 urine samples and compared with routine microbiological culture.

Results

E.coli was detected with 95.4% sensitivity and 96.1% specificity. Dynamics of the LAMP amplification could be used to gauge bacterial loads in the samples. Antibiotic sensitivity was detected with good negative (sensitive) predictive values: ampicillin 92.8%, ampicillin/sulbactam 96.4%, cefuroxime 92.8%, cefotaxime 97.8%, trimethoprim/sulfamethoxazole 96.5%, ciprofloxacin 96.8%.

Conclusion

The LAMP panel provided E.coli detection and sensitivity information within one hour and thus could principally guide initial antibiotic therapy upon patients presenting with UTI. The panel helps to select initial adequate antibiotic therapy as well as providing diagnostic stewardship. Follow up investigations will expand the test system to other uropathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliUrinary Tract InfectionsEscherichia coli InfectionsAnti-Bacterial AgentsNucleic Acid Amplification TechniquesMolecular Diagnostic TechniquesHumansMicrobial Sensitivity TestsSensitivity and SpecificityDrug Resistance, BacterialMaleUrineFemale

Stichwörter der Autor:innen

Antibiotic susceptibility testingAntimicrobial stewardshipFast microbiologyLoop-mediated isothermal amplificationPoint of care testingUrinary tract infections

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Institute of Medical Microbiology, Justus Liebig University Giessen, Giessen, Germany.
  • Clinic for Urology, Pediatric Urology and Andrology, Justus-Liebig-University, Giessen, Germany.
  • German Center for Infection Research (DZIF), partner site Giessen-Marburg-Langen, Giessen, Germany.
  • Bioinformatics and Systems Biology, Justus Liebig University Giessen, Giessen, Germany.
  • Institute of Laboratory Medicine and Pathobiochemistry, Phillips University, Marburg, Germany.
  • Institute of Medical Microbiology, Justus Liebig University Giessen, Giessen, Germany. can.imirzalioglu@mikrobio.med.uni-giessen.de.

Förderung

  • Justus-Liebig-Universität Gießen

Zitieren

APA

Fritzenwanker, M., Grabitz, M. O., Negwer, V., Schwengers, O., Arneth, B., Chakraborty, T., Imirzalioglu, C., & Wagenlehner, F. (2025). Genome-based development and clinical evaluation of a customized LAMP panel to rapidly detect, quantify, and determine antibiotic sensitivity of Escherichia coli in native urine samples from urological patients. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-05030-3

Vancouver

Fritzenwanker M, Grabitz MO, Negwer V, Schwengers O, Arneth B, Chakraborty T, et al. Genome-based development and clinical evaluation of a customized LAMP panel to rapidly detect, quantify, and determine antibiotic sensitivity of Escherichia coli in native urine samples from urological patients. European Journal of Clinical Microbiology & Infectious Diseases. 2025. doi:10.1007/s10096-024-05030-3

BibTeX
@article{Fritzenwanker2025,
  author = {Fritzenwanker, Moritz and Grabitz, Marcel O and Negwer, Vera and Schwengers, Oliver and Arneth, Borros and Chakraborty, Trinad and Imirzalioglu, Can and Wagenlehner, Florian},
  title = {Genome-based development and clinical evaluation of a customized LAMP panel to rapidly detect, quantify, and determine antibiotic sensitivity of Escherichia coli in native urine samples from urological patients},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2025},
  doi = {10.1007/s10096-024-05030-3}
}
Kostenlos starten →